Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06076564 · ClinicalTrials.gov registry record
Leveraging Psychological Autopsies to Accelerate Research Into Stimulant Overdose Mortality
A clinical trial of Overdose Accidental and Stimulant Overdose, sponsored by San Francisco Department of Public Health.
- Completed
- Registry status
- 176
- Enrollment target
- 1
- Study location
NCT06076564: Completed study of Overdose Accidental and Stimulant Overdose, sponsored by San Francisco Department of Public Health.
NCT06076564 is a study of Overdose Accidental and Stimulant Overdose that has completed, run by San Francisco Department of Public Health. The registered enrollment target is 176 participants, above the 156-participant average among 3 other Overdose Accidental trials with a reported enrollment target (13% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06076564, a study of Overdose Accidental and Stimulant Overdose, has completed, sponsored by San Francisco Department of Public Health.
- COMPLETED
- Registry status
- 176 participants
- Enrollment target
- 1
- Study location
Study Summary
In the LASSO study, the investigators will identify 100 stimulant overdose decedents (divided among stimulant-only, and stimulant with fentanyl), conduct informant interviews (including scales and qualitative data), and gather data from the postmortem investigation (e.g., vital records, toxicology, autopsy, case narrative, death scene photographs) and medical record abstraction. Subsequently, study staff will conduct qualitative interviews with 40-60 living people who use stimulants (aiming for half methamphetamine, half cocaine) to explore elements of resilience and risk reduction strategies. This study aims to contribute to the eventual design of interventions to reduce stimulant overdose mortality.
Primary Outcome
The investigators will use medical records and mortality data, as well as qualitative and quantitative interview data with close contacts, to identify medical, psychological, and substance use antecedents to stimulant overdose death.
Conditions Studied
Study Locations (1)
California
- San Francisco Department of Public Health - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 176 participants |
| Start Date | 2022-06-06 |
| Est. Completion | 2024-02-12 |
What the finished NCT06076564 record still lists
NCT06076564 is an observational study that tracks outcomes without assigning an intervention. The registered 176 participants enrollment target is mid-sized for trials with a published cap, above the 156-participant average among 3 other Overdose Accidental trials with a reported enrollment target (13% higher).
The record links to 4 conditions, with Overdose Accidental appearing as the primary indexed condition, and to 0 interventions.
NCT06076564 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06076564 about?
NCT06076564 is a clinical study titled "Leveraging Psychological Autopsies to Accelerate Research Into Stimulant Overdose Mortality". In the LASSO study, the investigators will identify 100 stimulant overdose decedents (divided among stimulant-only, and stimulant with fentanyl), conduct informant interviews (including scales and qualitative data), and gather data from the postmortem investigation (e.g., vital records, toxicology, ...
What is the current status of trial NCT06076564?
This trial is currently completed. The enrollment target is 176 participants. The study started on 2022-06-06. Estimated completion is 2024-02-12.
What conditions does trial NCT06076564 study?
This clinical trial studies the following conditions: Overdose Accidental, Stimulant Overdose, Overdose Cocaine, Overdose Methamphetamine.
Who is sponsoring clinical trial NCT06076564?
This trial is sponsored by San Francisco Department of Public Health, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06076564 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overdose Accidental
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03304821 · 176 participants · Phase 2
Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease
- NCT03447938 · 176 participants · NA
The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial
- NCT03824145 · 176 participants · NA
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
- NCT04177914 · 176 participants · Phase 3
HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI